However, like many medications, semaglutide can have side effects
The novel synergistically acting glucagon-like peptide-1 (GLP-1) receptor agonist combined with the amylin agonist, CagriSema, shows promising results in both glucose regulation and weight management
Furthermore, GLP-1 RA is the only drug class that reduces the risk of stroke (Lin et al., 2021)
The mechanisms underlying the prevention of cancer by GLP-1RAs Improvement in Insulin sensitivity and glycemic control Chronic hyperglycemia, insulin resistance, and secondary hyperinsulinemia are widely acknowledged as significant risk factors that contribute to tumorigenesis and heightened cancer mortality rates [3, 11]
With glipizide, hypoglycemia is a more common side effect and can sometimes be more severe
Its considered one of the single most important antioxidants in your body because it fulfils so many vital protective tasks in your metabolism